M P Yavropoulou1, G Panagiotou2, K Topouridou1, G Karayannopoulou3, T Koletsa3, T Zarampoukas4, A Goropoulos5, E Chatzaki6, J G Yovos1, K Pazaitou-Panayiotou7. 1. Division of Endocrinology and Metabolism, 1st Department of Internal Medicine, AHEPA University Hospital, Thessaloniki, Greece. 2. Department of Endocrinology-Endocrine Oncology, Theagenio Cancer Hospital, 2 Al Simeonidi Str, 54007, Thessaloniki, Greece. 3. Pathology Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. 4. Histopathology Laboratory, Istodierevnitiki S.A, Thessaloniki, Greece. 5. Department of Endocrine Surgery, Saint Luke's General Hospital, Thessaloniki, Greece. 6. Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece. 7. Department of Endocrinology-Endocrine Oncology, Theagenio Cancer Hospital, 2 Al Simeonidi Str, 54007, Thessaloniki, Greece. kpazaitoupanayiotou@gmail.com.
Abstract
PURPOSE: Vitamin D receptor (VDR) and progesterone receptor (PR) expression has been described in papillary thyroid carcinoma (PTC) but data regarding association with tumor histological characteristics and localization of the protein expression are scarce. MATERIALS AND METHODS: Formalin-fixed, paraffin-embedded specimens from 45 patients with PTC (cases) were retrieved and tumor histological data were recorded. We analyzed gene and protein expression of VDR and PR and gene expression of vitamin D-inactivating 24-hyroxylase (CYP24A1) and the activating 1-alpha-hydroxylase (CYP27B1) enzymes in follicular cancer cells and the adjacent non-neoplastic thyroid tissue (NNTT). RESULTS: VDR mRNA and protein expression was higher in PTC compared with NNTT (p < 0.05). The protein was globally localized in the cytoplasm and cell membranes of the neoplastic cells in all cases, with differences in intensity. Cytoplasmic positivity was stronger in the majority of cases. Membranous positivity was also evident in cases, whereas in NNTT was generally weak and in a low percentage of the cells. Expression of CYP 24A1, but not CYP27B1, was increased in approximately all PTC specimens and was associated with lymph node metastasis and extrathyroidal extension. PR mRNA was increased in 34% and protein expression was present in 57% of cases, and none of NNTT. PR, but not VDR, mRNA expression was significantly associated with the tumor size (r = 0.645, p = 0.007). CONCLUSIONS: We provide evidence for the expression pattern of VDR, PR and CYP24A1 in the progression of PTC. Rapid anti-tumor responses of vitamin D in PTC may be blocked due to inactivation of local vitamin D metabolism.
PURPOSE:Vitamin D receptor (VDR) and progesterone receptor (PR) expression has been described in papillary thyroid carcinoma (PTC) but data regarding association with tumor histological characteristics and localization of the protein expression are scarce. MATERIALS AND METHODS:Formalin-fixed, paraffin-embedded specimens from 45 patients with PTC (cases) were retrieved and tumor histological data were recorded. We analyzed gene and protein expression of VDR and PR and gene expression of vitamin D-inactivating 24-hyroxylase (CYP24A1) and the activating 1-alpha-hydroxylase (CYP27B1) enzymes in follicular cancer cells and the adjacent non-neoplastic thyroid tissue (NNTT). RESULTS:VDR mRNA and protein expression was higher in PTC compared with NNTT (p < 0.05). The protein was globally localized in the cytoplasm and cell membranes of the neoplastic cells in all cases, with differences in intensity. Cytoplasmic positivity was stronger in the majority of cases. Membranous positivity was also evident in cases, whereas in NNTT was generally weak and in a low percentage of the cells. Expression of CYP 24A1, but not CYP27B1, was increased in approximately all PTC specimens and was associated with lymph node metastasis and extrathyroidal extension. PR mRNA was increased in 34% and protein expression was present in 57% of cases, and none of NNTT. PR, but not VDR, mRNA expression was significantly associated with the tumor size (r = 0.645, p = 0.007). CONCLUSIONS: We provide evidence for the expression pattern of VDR, PR and CYP24A1 in the progression of PTC. Rapid anti-tumor responses of vitamin D in PTC may be blocked due to inactivation of local vitamin D metabolism.
Authors: Craig M Bula; Johanna Huhtakangas; Christopher Olivera; June E Bishop; Anthony W Norman; Helen L Henry Journal: Endocrinology Date: 2005-09-08 Impact factor: 4.736
Authors: David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle Journal: Thyroid Date: 2009-11 Impact factor: 6.568
Authors: Laura R Lee; Pang-Ning Teng; Huyen Nguyen; Brian L Hood; Leyla Kavandi; Guisong Wang; Jane M Turbov; Larry G Thaete; Chad A Hamilton; George L Maxwell; Gustavo C Rodriguez; Thomas P Conrads; Viqar Syed Journal: Cancer Prev Res (Phila) Date: 2013-05-16
Authors: Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf Journal: Cell Date: 2006-08-25 Impact factor: 41.582
Authors: A M Cocolos; S Vladoiu; A Caragheorgheopol; A M Ghemigian; D Ioachim; C Poiana Journal: Acta Endocrinol (Buchar) Date: 2022 Apr-Jun Impact factor: 1.104
Authors: Florian Viehweger; Lisa-Marie Tinger; David Dum; Natalia Gorbokon; Anne Menz; Ria Uhlig; Franziska Büscheck; Andreas M Luebke; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Christoph Fraune; Patrick Lebok; Sören Weidemann; Maximilian Lennartz; Frank Jacobsen; Till S Clauditz; Rainer Krech; Till Krech; Andreas H Marx; Ronald Simon; Eike Burandt; Stefan Steurer; Guido Sauter; Sarah Minner; Christian Bernreuther Journal: Anal Cell Pathol (Amst) Date: 2022-08-08 Impact factor: 4.133